Blood News and Research

RSS

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.

8 Jan 2010

Exercise, nutrition and hormone optimization are key to improve men's health issues

Grant Mansell was 46 and frustrated with his 300 pound physique, ensuing back pain, rising cholesterol, dependency on blood pressure medicine but most of all not enjoying life with his wife and children.

8 Jan 2010

LSUHSC receives $2.1 million grant for pneumonia research

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

8 Jan 2010

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

7 Jan 2010

Carolinas MED-1 to house a clinic for residents to get H1N1 Flu shots

Carolinas MED-1 - the first mobile hospital of its kind in the world - will be serving the people of Charlotte and Mecklenburg County when it is deployed this Saturday for an H1N1 vaccine clinic.

7 Jan 2010

Prolias acquires UMBI's technology to develop human therapeutic antibodies

Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease, today announced a strategic acquisition of technology from the University of Maryland Biotechnology Institute (UMBI).

7 Jan 2010

New genetic findings may lead to better interventional therapies for obsessive compulsive disorders

A collaboration between the University of Massachusetts Medical School, the Cummings School of Veterinary Medicine at Tufts University and the Broad Institute at the Massachusetts Institute of Technology has identified a genetic locus on canine chromosome 7 which coincides with an increased risk of obsessive compulsive disorder (OCD) susceptibility.

7 Jan 2010

High or low blood calcium levels linked to increased risk of premature death in kidney disease patients

Abnormally high or low blood calcium levels are linked to an increased chance of premature death in non-dialysis kidney disease patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

7 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

CFIDS Association of America issues statement in response to XMRV study

The CFIDS Association of America issued the following statement in response to a study published in today’s edition of PLoS One that failed to detect the XMRV virus in banked samples drawn from 186 CFS patients in the United Kingdom. A study published Oct. 8, 2009 in Science reported that 68 of 101 CFS patients from clinics in the U.S. tested positive for XMRV.

7 Jan 2010

Scientists develop first-of-its-kind cloth that releases nitric oxide gas

Scientists in Texas are reporting development of a first-of-its-kind cloth that releases nitric oxide gas - an advance toward making therapeutic socks for people with diabetes and a wrap to help preserve organs harvested for transplantation. The study is in ACS' Chemistry of Materials, a bi-weekly journal.

7 Jan 2010

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy

Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say.

7 Jan 2010

Researchers seek to defeat Alzheimer's disease by modifying mice's immune system

Using laboratory mice that had been bred to have brain changes similar to Alzheimer's disease, scientists were able to reduce two characteristic features of the disease by modifying the mice's immune systems with a special peptide (MOG45D) related to the myelin sheath that insulates nerve cells and nerve fibers. As a result, anti-inflammatory cells were recruited from the blood into the brain, dampening the local inflammatory response.

7 Jan 2010

Penn researchers study benefits of bariatric surgery for treating Type 2 diabetes

A multi-disciplinary team of Penn researchers, including diabetes, weight loss and bariatric surgery experts, are conducting a study funded by the National Institutes of Health (NIH) to determine if bariatric surgery, either gastric bypass or adjustable gastric banding surgery, is more effective than lifestyle modification to reduce weight and ultimately treat Type 2 diabetes.

7 Jan 2010

E-The Environmental Magazine: Environmental toxicity drives up autism rates

As many as one in 90 children are today being diagnosed with autism--and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates--environmental toxicity.

7 Jan 2010

Study suggests pomegranates may prevent growth of breast cancer cells

US scientists have carried out a series of laboratory tests suggesting that natural compounds in pomegranates may prevent the growth of breast cancer cells.

7 Jan 2010

ProFibrix B.V. receives loan up to $7.4 million to develop its new hemostat Fibrocaps

ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM).

7 Jan 2010

Vignet releases Connected Health Services platform infrastructure for mHealth devices and services

Vignet Inc., today announced its Connected Health Services platform infrastructure for mobile health (mHealth) devices and services. The new “person-centered” platform allows users to capture, aggregate, analyze and share data with their mobile devices, leveraging any wired or wireless interface, such as Bluetooth, ZigBee, Bluetooth LE and USB.

7 Jan 2010

UMBI announces exclusive licensing of fully human antibody technology platform to Prolias

The University of Maryland Biotechnology Institute (UMBI) today announced the exclusive licensing of a fully human antibody technology platform to Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease.

7 Jan 2010

Researchers identify new approach to eliminate side effects of drugs

Researchers at the Stanford University School of Medicine have taken an early step toward identifying a new approach to drug discovery that may eventually yield drugs with fewer side effects.

7 Jan 2010

Blood News and Research

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Exercise, nutrition and hormone optimization are key to improve men's health issues

LSUHSC receives $2.1 million grant for pneumonia research

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

Carolinas MED-1 to house a clinic for residents to get H1N1 Flu shots

Prolias acquires UMBI's technology to develop human therapeutic antibodies

New genetic findings may lead to better interventional therapies for obsessive compulsive disorders

High or low blood calcium levels linked to increased risk of premature death in kidney disease patients

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

CFIDS Association of America issues statement in response to XMRV study

Scientists develop first-of-its-kind cloth that releases nitric oxide gas

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy

Researchers seek to defeat Alzheimer's disease by modifying mice's immune system

Penn researchers study benefits of bariatric surgery for treating Type 2 diabetes

E-The Environmental Magazine: Environmental toxicity drives up autism rates

Study suggests pomegranates may prevent growth of breast cancer cells

ProFibrix B.V. receives loan up to $7.4 million to develop its new hemostat Fibrocaps

Vignet releases Connected Health Services platform infrastructure for mHealth devices and services

UMBI announces exclusive licensing of fully human antibody technology platform to Prolias

Researchers identify new approach to eliminate side effects of drugs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News